Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices – results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment)

Table 8 Considered results of the main study^a

	Intervention (n = 365)	Control (n = 371)	Total (n = 736)
Occurrence of primary endpoint: patients suffering a thromboembolic or major bleeding event, no. (%)^b	40 (11.0)	48 (12.9)	88 (12%)
Hospitalized patients, no. (%)	184 (50.4)	209 (56.5)	393 (53.5%)
Days of hospitalization per patient, mean (SD)^c	12.7 (24.9)	14.5 (24.1)	13.6 (24.5)

^aThis table shows results of the intention-to-treat analysis of the main study, which can be seen in detail in the corresponding paper [24]. It is shown here, because these results were included in the linear mixed model analysis (see Tables 5 and 7)
^bIf more than one event occurred in a patient, the earliest event was counted
^cOf those patients ever hospitalized

ISSN: 1472-6963